Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 4Leukemia 4Myelodysplastic Syndromes 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Lymphocytic, Chronic, B-Cell 2Graft vs Host Disease 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Non-Malignant Neoplasm 1Neuroblastoma 1Multiple Myeloma 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1Lymphoma 1Leukemia, Prolymphocytic 1Immunologic Deficiency Syndromes 1Hodgkin Disease 1Hematologic Neoplasms 1Anemia 1

Interventions

fludarabine phosphate 4Peripheral Blood Stem Cell Transplantation 3Cytarabine 3fludarabine 2Tacrolimus 2Rituximab 2Oxaliplatin 2Methotrexate 2Clofarabine 2Busulfan 2Antilymphocyte Serum 2veltuzumab 1thymoglobulin 1pegfilgrastim 1ofatumumab 1merphos 1ethanolamine oleate 1dinaciclib 1carmustine, poliferprosan 20 drug combination 1acalabrutinib 1Whole-Body Irradiation 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Sulfamethoxazole 1Sodium Chloride 1Saline Solution, Hypertonic 1Saline Solution 1Pentetic Acid 1Mycophenolic Acid 1Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Leukemia, Prolymphocytic × thymoglobulin × Clear all
NCT01629511 2020-02-24

Allogeneic Stem Cell Transplant for CLL

M.D. Anderson Cancer Center

Phase 1/2 Terminated
15 enrolled 12 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡